IDERA PHARMACEUTICALS INC - COM PAR (IDRA)

CUSIP: 45168K405

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COM PAR
Total 13F shares
9,019,560
Share change
-454,050
Total reported value
$16,416,198
Price per share
$1.82
Number of holders
43
Value change
-$971,484
Number of buys
10
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 45168K405?
CUSIP 45168K405 identifies IDRA - IDERA PHARMACEUTICALS INC - COM PAR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IDERA PHARMACEUTICALS INC - COM PAR (IDRA) as of Q4 2019

As of 31 Dec 2019, IDERA PHARMACEUTICALS INC - COM PAR (IDRA) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,019,560 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, OXFORD ASSET MANAGEMENT LLP, JACOBS LEVY EQUITY MANAGEMENT, INC, and ACADIAN ASSET MANAGEMENT LLC. This page lists 43 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.